Episodic Future Thinking for HIV Prevention
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be currently taking HIV PrEP medication to participate.
What data supports the effectiveness of the treatment Exteroceptively Focused Treatment (EFT) for HIV prevention?
Research shows that episodic future thinking (EFT) can improve decision-making and reduce impulsive behaviors, which are beneficial in managing addictive behaviors and substance use. These findings suggest that EFT might help individuals make better choices regarding HIV prevention by enhancing their ability to think about future consequences.12345
Is Episodic Future Thinking (EFT) safe for humans?
How is the treatment Episodic Future Thinking (EFT) unique for HIV prevention?
Episodic Future Thinking (EFT) is unique because it involves mentally simulating future events to improve decision-making and behavior, which is different from traditional treatments that might focus on medication or direct behavioral interventions. This approach has shown promise in other areas like substance use and weight loss by enhancing future planning and reducing impulsive behaviors.12369
What is the purpose of this trial?
This research study is testing a new behavioral therapy called Episodic Future Thinking or EFT can help people reduce drug use and risky sexual behaviors while helping them adhere to their HIV prevention medication (PrEP). Participants will be randomly assigned to one of two groups. One group will receive standard care, which includes counseling on HIV prevention, drug use reduction, and sexual health. The other group will receive standard care plus a new program called Episodic Future Thinking (EFT), where participants will think about and plan for their future goals using a mobile app and counseling sessions. Study procedures that are not part of regular care include filling out surveys, providing blood, urine, and swab samples for testing, and using the EFT app.
Research Team
Emeka Okafor, PhD, MPH
Principal Investigator
The University of Texas Health Science Center at San Antonio
Eligibility Criteria
This trial is for sexual minority individuals who are interested in reducing drug use and risky sexual behaviors, while also adhering to HIV prevention medication. Participants should be willing to provide biological samples and use a mobile app as part of the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Formative Evaluation
Qualitative interviews with sexual minority individuals to evaluate the Episodic Future Thinking intervention
Treatment
Participants are randomly assigned to either standard care or standard care plus Episodic Future Thinking intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments for PrEP adherence, drug use, and STI testing
Treatment Details
Interventions
- EFT
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator